Wuxi Biologics (Cayman) Financial Overview
Wuxi Biologics (Cayman)'s market cap is currently HK$141.02B. The company's EPS TTM is HK$0.606853698; its P/E ratio is 29.73; Wuxi Biologics (Cayman) is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is HK$0.62. See an overview of income statement, balance sheet, and cash flow financials.
